ArticleBMC anesthesiology2025
Steroid versus steroid plus ozone during posterior epiduroscopy in the treatment of lumbar herniated disc: results of a 1-year follow-up study.
Article in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Efficacy of ozone with steroid injection therapy in lumbar disc herniation: meta-analysis.Frontiers in medicine · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOzone has recently been employed in the treatment of low back pain which is a prevalent cause of disability in the population. The objective of this study was to evaluate the effects of the steroids alone or steroids plus ozone during epiduroscopy for chronic low back and radicular lower extremity pain.
methodsThe files of 76 individuals with chronic lumbar and lower extremity pain who had undergone posterior epiduroscopy were analyzed. One group applied steroids and standard treatment with saline for mechanical disintegration of scarring tissue in the epidural area. Other patients were injected with ozone and steroids in addition to standard treatment. Oswestry Disability Index (ODI) and Visual Analogue Scale (VAS) scores were performed before and following the intervention, at the 1st, 3rd, 6th, and 12th months. The degree of epidural scar tissue was also recorded during epiduroscopy. The classification of pain as either neuropathic or non-neuropathic was determined by the DN4 (Douleur Neuropathique 4) questionnaire. Results of the Patients Satisfaction Scale were noted in the 12th month. Pre- and post-procedure analgesic use and complications were recorded.
resultsThere were 35 and 41 patients in the steroid alone and steroid plus ozone groups, respectively. Patient characteristics were similar, and both treatment groups showed significant differences in mean VAS and ODI scores compared to baseline (p˂0.001). However, the reduction in VAS scores was more significant in the ozone-added patients. The mean disability scores were comparable for the two groups at all follow-up points. Neuropathic pain was present in 42.9% of patients in the steroid-alone group and 34.1% in the combination group and, on follow-up 11 and 25 patients discontinued medication. The findings revealed the presence of moderate to severe fibrous tissue in 94.3% and 80.5% of the patients, respectively. Satisfied/very satisfied with the procedure was reported by 71% of subjects in the steroid-alone group and 92% of subjects in the steroid-plus-ozone group.
conclusionThe combination of epidural ozone with steroids may be a viable option for the management of persistent lumbar and radicular limb pain. For individuals with lumbar herniated discs, this modality has been demonstrated to be both safe and efficacious. CLINICAL TRIAL NUMBER: Not applicable (Retrospective Study).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.